BT1769 is a MT1-MMP-targeted (KD = 3.35 nM) Bicycle toxin conjugate. BT1769 can be used in the study for osteosarcoma. BT1769 consists of a novel bicyclic targeting peptide that selectively binds MT1-MMP, a cytotoxin MMAE, and an enzymatically cleavable dipeptide linker[1].
Molecular Weight:
3939.45
Formula:
C186H269N43O50S
Target:
MMP,Peptide-Drug Conjugates (PDCs)
Application Notes:
Peptides
* VAT and and shipping costs not included. Errors and price changes excepted
